News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Omar M. Abu Saleh, MBBS

Advertisement

Omar M. Abu Saleh, MBBS, is an assistant professor of medicine and a senior associate consultant at the Division of Infectious Diseases at Mayo Clinic in Rochester, Minnesota.

Articles by Omar M. Abu Saleh, MBBS

Eagerly Awaited Trial on Periprosthetic Joint Infections Reinforces Practice

ByDon Bambino Geno Tai, MD,Christina G. Rivera, PharmD,Omar M. Abu Saleh, MBBS
August 16th 2021
Advertisement

Latest Updated Articles

  • Eagerly Awaited Trial on Periprosthetic Joint Infections Reinforces Practice
    Eagerly Awaited Trial on Periprosthetic Joint Infections Reinforces Practice

    Published: August 16th 2021 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients

2

Invivyd Announces FDA Clearance of IND Application for VYD2311 and Advancement of REVOLUTION Clinical Program

3

UCF Team Advances Low-Cost Multiplex RNA Test for HIV, HBV, and HCV

4

Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Postantibiotic Era

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us